Madison Avenue Partners, LP Ovid Therapeutics Inc. Call Options Transaction History
Madison Avenue Partners, LP
- $591 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding OVID
# of Institutions
77Shares Held
39.4MCall Options Held
10.3KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$6.91 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$5.19 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$5.01 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$4.02 Million0.0% of portfolio
-
Artal Group S.A. Luxembourg, N42.5MShares$3.25 Million0.12% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $91.5M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...